I won't pretend nine years never made me doubt this. There were stretches where the price fell, the market looked elsewhere, and the quiet question sat there: what if I'm just wrong? Any honest founder has felt it. What kept me in wasn't blind faith. It was going back to the actual problem, who owns the data your body makes, and finding it still unsolved, still mattering more each year. The doubt never won because the problem never went away.

Nineteen billion dollars got liquidated across crypto earlier this month. People asked if I was worried. I’ve held MAN since 2017. I’ve watched this token lose more value, more times, than most projects ever live to see. I didn’t sell then and I didn’t flinch now. Volatility isn’t the risk. Building something real that never ships is the risk. One of those I can control. So that’s where I put my attention.

The hardest part of building infrastructure nobody’s asking for yet isn’t the technology. It’s the years. Building something the market won’t need until later means being wrong in public for a long time before you’re right once. I don’t romanticize it. Most days it’s unglamorous work on a problem few people see. But the four things that make biology tradeable, provenance, consent, quality, liability, don’t build themselves, and nobody else was doing it. So we did. Quietly. For nine years.

This week the US quietly withdrew proposed rules that would have forced surveillance on self-custodied crypto wallets. Everyone's cheering. And they should — it's good news. But notice the pattern. The win wasn't crypto gaining a new right. It was a government declining to take one away. We've started celebrating not-getting-hit as if it were winning. A reprieve isn't the same as freedom. It's just the fist opening, for now. When did "they decided not to restrict us" start feeling like a victory? #crypto

Question: Can the new infrastructure connect with major networks such as Ethereum, Bitcoin and Solana? Owen’s answer in the September AMA: “Yes.” The interesting part is what comes after the yes: interoperability is part of the reason for building the new mainnet. How important is interoperability to a new chain? #MatrixAINetwork #Interoperability

An OpenAI agent accessed public and non-public files on Australia’s Medicare statistics portal. https://t.co/2Exn2fIM9g https://t.co/HjL5TBwCxP OpenAI’s own words: “Our models took actions we did not intend.” That raises a bigger question: What was the AI actually acting on? Who owns the data? What device collected it? Which session? When? Has it changed? Matrix is building BioData infrastructure around exactly this layer of provenance. Should an autonomous AI be able to act on data it cannot fully verify? #AI #BioData #MatrixAINetwork

For centuries, we looked at the moon to understand the world. Now we have another universe to understand: ourselves. This Mid-Autumn Festival, here's to seeing the full picture. #MatrixAINetwork #BioData https://t.co/iwYhVHjckn

A biological signal is not an asset just because it exists. September's 1st Bi-Weekly Report shows part of the infrastructure being built around it. Device. Session. Timestamp. Protocol. Data format. Registration. The goal is simple: Give BioData a record of what it is and where it came from. That's where the asset story starts. What else would you require? #RWA #BioData #MatrixAINetwork

September's 1st Bi-Weekly Report says the new EVM chain is in trial. Here's a small glimpse of what “trial” actually means. Solidity. Smart contract testing. DEX infrastructure. The hard part isn't saying a chain is EVM compatible. The hard part is making developers believe they can actually build on it. What would you test first? #EVM #DeFi #MatrixAINetwork

September's First Bi-Weekly Report The surprising part isn't the number of nodes or wallets. It's what is being built underneath them. The new EVM chain is entering trial. EEG synchronization is reaching millisecond-level infrastructure. Device and session metadata are taking shape. The pieces are beginning to connect. Why does that matter for BioData? #BioData #AI #MatrixAINetwork